-
-
Your cart is empty
- Register Now
Event description put here
@my_event_day
- Sunday, 05 November 2022
- 2:00 PM – 3:30PM
- Mas Montagnette
- 198 West 21th Street, NY
- +1 485-048-1995
Forum's Scientific Agenda
Day 1
Registration: 08:30 am
Opening Remarks: 08:45 am
Nik Tezapsidis
President & CEO
Presentation 1
09:00 am
Procognitive Memtin: replacing low leptin levels in early Alzheimer’s, a de-risked and personalized approach
Procognitive Memtin, a new drug, could help early Alzheimer’s patients by replacing low leptin levels. This personalized approach could be a promising new treatment
Anka G. Ehrhardt
Director, Cell-Based
Presentation 2
09:30 am
Designing Pragmatics Trials That Are Fit for Purpose
Pragmatic trials are designed to test interventions in real-world settings. To be fit for purpose, they should be relevant to clinicians and patients, and their results should be generalizable to everyday practice.
Networking Break: 10:00 am – 11:00 am
Anna Kazanchyan
CEO & Chairwoman
Presentation 3
11:00 am
How to build a resilient Pharma/biotech company: Lessons Learned
Build a resilient pharma/biotech company by investing in early-stage research, building a diverse pipeline, partnering, and creating a culture of collaboration, risk-taking, and learning.
Peter Henstock
Mach. Learning & AI Tech
Presentation 4
11:30 am
Risk-Based Monitoring & Quality Mgmt of Clinical Trials
RBM/QM uses data and analytics to identify and mitigate risks, ensuring that clinical trials are conducted efficiently and safely, with high-quality data.
Jay Russak
Sr. Director
Presentation 5
12:00 pm
Remote Monitoring and Risk-Based approaches: impact on budgets and resources
Remote monitoring and risk-based approaches can optimize clinical trial budgets and resources by reducing travel costs, streamlining workflows, and increasing efficiency.
Lunch Break: 12:30 pm – 01:30 pm
Cheng Fang
Sr. VP of R&D
Presentation 6
01:30 pm
Clinical Trials: Design, Strategy, and Analysis
Design, strategy, and analysis are essential for successful clinical trials. This topic covers the latest approaches to ensure that trials are efficient, effective, and meet the needs of patients and sponsors.
Frank Leu
CEO
Presentation 7
02:00 pm
Disrupting technologies, Blockchain and AI, are catalysts for seamsless Drug development
Blockchain and AI are transforming drug development, making it more seamless, efficient, and secure. This topic explores the latest applications of these technologies and their impact on the industry.
Earle Holsapple
President
Presentation 8
02:30 pm
Collaborative Clinical Ecosystem; how to Effectively manage partnerships with patients, sites, CROs, sponsors, and regulators
Effective partnerships are essential for successful clinical trials. This topic covers strategies for managing partnerships with patients, sites, CROs, sponsors, and regulators to achieve common goals.
Networking Break: 03:00 pm – 04:00 pm
Abdulkader Rahmo
President & CSO
Presentation 9
04:00 pm
Developing an effective clinical outsourcing strategy; analyzing risks and benefits
Outsourcing clinical trials can offer benefits such as cost savings and access to expertise. However, it is important to carefully analyze the risks and benefits before making a decision. This topic covers strategies for developing an effective clinical outsourcing strategy.
Dena House
SVP of HR, OD & Learning
Presentation 10
04:30 pm
How to decide what to outsource and what to do in-house? inventing the new rule of thumb
Deciding what to outsource and what to do in-house is a complex decision. This topic provides a framework for making this decision based on factors such as cost, expertise, and risk.
Closing Remarks: 05:00 pm – 05:15 pm
Day 2
Registration: 08:30 am
Opening Remarks: 08:45 am
Shane Hegarty
CSO & Co-Founder
Presentation 1
09:00 am
Different Models of Study Partnerships, a framework to analyze which works better for your company
There are different models of study partnerships, each with its own advantages and disadvantages. This topic provides a framework for analyzing which model is best suited for your company.
Tina Runk
Co-Founder, Director & EVP
Presentation 2
09:30 am
Creating an effective vendor audit process with a risk-based approach to ensure success in remote trials
Effective vendor audits are essential for ensuring the quality and success of remote trials. This topic covers how to create a risk-based vendor audit process that meets the needs of your organization.
Networking Break: 10:00 am – 11:00 am
Mary Potasek
Chief Scientific Officer
Presentation 3
11:00 am
Novel Light-Based Cancer Therapy: Clinical Trial Reshaping the Future
Novel light-based cancer therapies are showing promising results in clinical trials. This topic explores the latest advances in this field and their potential to revolutionize cancer treatment.
Briana Belford
Managing Director
Presentation 4
11:30 am
Fundraising for studies, ensuring a steady stream of money for research
Fundraising is essential for sustaining clinical research. This topic covers strategies for raising funds for clinical trials from a variety of sources, such as government grants, private investors, and philanthropic donations.
Safwan Kezbor
Medical Director
Presentation 5
12:00 pm
How to make cost projections and preparing investor’s reports
Accurate cost projections and investor reports are essential for securing funding for clinical trials. This topic covers how to develop and prepare these documents effectively.
Lunch Break: 12:30 pm – 01:30 pm
To Be Disclosed
To Be Disclosed
Presentation 6
01:30 pm
What we look in a pharma-biotech company: A VC’s perspective
Venture capitalists (VCs) play a vital role in funding clinical trials. This topic provides a VC’s perspective on what they look for in a pharma-biotech company.
To Be Disclosed
To Be Disclosed
Presentation 7
02:00 pm
Disrupting technologies, Blockchain and AI, are catalysts for seamless Drug development
Blockchain and AI are transforming drug development, making it more seamless, efficient, and secure. This topic explores the latest applications of these technologies and their impact on the industry.
To Be Disclosed
To Be Disclosed
Presentation 8
02:30 pm
Harnessing Technology for Clinical Process Automation and Enhanced Efficiency
Technology can be used to automate and streamline clinical processes, leading to enhanced efficiency and cost savings. This topic explores the latest technologies available for clinical process automation.
Networking Break: 3:00 pm – 4:00 pm
To Be Disclosed
To Be Disclosed
Presentation 9
04:00 pm
Using AI to automate clinical data, from protocol to submission
Artificial intelligence (AI) can be used to automate various tasks in clinical data management, from protocol development to submission. This topic explores the latest AI-powered solutions for clinical data automation.
To Be Disclosed
To Be Disclosed
Presentation 10
04:30 pm
Modernizing Data Review with a Centralized Platform
Centralized data review platforms can help to modernize clinical data review, making it more efficient, accurate, and secure. This topic explores the latest centralized data review platforms and their benefits.
Closing Remarks: 05:00 pm – 05:15 pm